TABLE III.
Reported Engagement Rating (Trial No.) |
SFC for FaceROI as % of total SFC (%) |
SFC for NonFaceROI as % of total SFC (%) |
FDAVG; for FaceROI (ms) |
FDAVG; for NonFaceROI (ms) |
||||||
---|---|---|---|---|---|---|---|---|---|---|
LE | HE | LE | HE | LE | HE | LE | HE | LE | HE | |
ASDl | 2(1) | 5(4) | 56 | 80.5 | 44 | 19.5 | 315 | 363 | 312 | 313 |
ASD2 | 6(5) | 7(1) | 80 | 88.2 | 20 | 11.8 | 319 | 339 | 254 | 297 |
ASD3 | 4(1) | 7(4) | 77.7 | 98.5 | 22.3 | 1.5 | 298 | 379 | 300 | 322 |
ASD4 | 6(1) | 9(2) | 89.1 | 98.8 | 10.9 | 1.2 | 343 | 354 | 342 | 297 |
ASD5 | 3(3) | 6(4) | 79.3 | 84.9 | 20.7 | 15.1 | 272 | 296 | 269 | 288 |
ASD6 | 4(1) | 7(4) | 69.7 | 84.7 | 30.3 | 15.3 | 295 | 307 | 301 | 305 |
LE : Lowest Rating on Engagement; HE : Highest Rating on Engagement SFC: Sum of Fixation Counts; FDAVG: Average Fixation Duration